Australia’s BioCina and NovaCina join forces to make one CDMO

Pri­vate in­vest­ment firm Bridgewest is com­bin­ing its Aus­tralia-based bi­o­log­ics CD­MO BioCi­na and its ster­ile in­jectable man­u­fac­tur­er No­vaCi­na in­to one com­pa­ny.

The new CD­MO will con­tin­ue …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.